// App-Quantinova.ai

219 : Converting patients with chronic myositis from maintenance intravenous immunoglobulin therapy to rituximab in England: a potential saving of £1.7 million per year

Researchers

Presenter

  • Alexander Oldroyd

Principal Investigators

  • Bridget Griffiths

  • Patrick Gordon

  • Hector Chinoy

Medical Centers

  • Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK

  • NIHR Manchester Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UNITED KINGDOM

  • Rheumatology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UNITED KINGDOM

  • Rheumatology, Bolton Hospitals NHS Foundation Trust, Bolton, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Myositis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved